Acute hepatitis secondary to febuxostat.

Miryam Moreta RodríguezCarlos Maroto MartinFrank Suárez LópezJavier Miguel Martín Guerra

Published in: Revista espanola de enfermedades digestivas (2023)

Febuxostat is a drug from the group of xanthine dehydrogenase inhibitors and is used in the treatment of hyperuricemia and gouty arthritis. However, it is not free of adverse effects, including alteration of liver profile tests. This is why we must pay attention to this type of adverse events in case it is necessary to suspend treatment. We present a clinical case of acute hepatitis secondary to Febuxostat.

Keyphrases

liver failure
respiratory failure
rheumatoid arthritis
aortic dissection
health insurance
extracorporeal membrane oxygenation
replacement therapy